Free Trial

Evoke (LON:EVOK) Trading Up 17.2% - Time to Buy?

Evoke logo with Consumer Cyclical background

Evoke plc (LON:EVOK - Get Free Report)'s share price traded up 17.2% on Wednesday . The company traded as high as GBX 45.90 ($0.60) and last traded at GBX 44.30 ($0.58). 3,500,189 shares were traded during trading, an increase of 35% from the average session volume of 2,588,063 shares. The stock had previously closed at GBX 37.80 ($0.49).

Analyst Ratings Changes

Separately, Jefferies Financial Group reissued a "buy" rating and issued a GBX 140 ($1.83) price objective on shares of Evoke in a research note on Monday, December 16th.

Check Out Our Latest Report on Evoke

Evoke Stock Up 2.8 %

The firm has a market cap of £213.18 million, a P/E ratio of -1.19 and a beta of 0.84. The stock's 50-day moving average is GBX 62.59 and its 200-day moving average is GBX 62.11.

Evoke (LON:EVOK - Get Free Report) last announced its quarterly earnings data on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, analysts expect that Evoke plc will post 12.7648305 EPS for the current fiscal year.

Insider Activity at Evoke

In related news, insider Jonathan (Jon) Mendelsohn bought 200,000 shares of the company's stock in a transaction on Monday, March 31st. The stock was bought at an average cost of GBX 48 ($0.63) per share, with a total value of £96,000 ($125,605.13). Also, insider Andrea Gisle Joosen bought 14,572 shares of the company's stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average price of GBX 70 ($0.92) per share, with a total value of £10,200.40 ($13,346.07). 27.00% of the stock is currently owned by insiders.

Evoke Company Profile

(Get Free Report)

Featured Articles

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines